| 0 |
RASH |
15 |
| 1 |
ACNE |
10 |
| 2 |
SUNBURN |
10 |
| 3 |
ERYTHEMA |
9 |
| 4 |
DRY SKIN |
8 |
| 5 |
MALIGNANT MELANOMA |
8 |
| 6 |
HEADACHE |
7 |
| 7 |
OFF LABEL USE |
7 |
| 8 |
APPLICATION SITE ERYTHEMA |
6 |
| 9 |
APPLICATION SITE PAIN |
6 |
| 10 |
DERMATITIS |
6 |
| 11 |
PAIN |
6 |
| 12 |
PHOTOSENSITIVITY REACTION |
6 |
| 13 |
SWELLING FACE |
6 |
| 14 |
ARTHRALGIA |
5 |
| 15 |
BLISTER |
5 |
| 16 |
CONDITION AGGRAVATED |
5 |
| 17 |
DEPRESSION |
5 |
| 18 |
DIARRHOEA |
5 |
| 19 |
DRUG INEFFECTIVE |
5 |
| 20 |
FATIGUE |
5 |
| 21 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
5 |
| 22 |
PRODUCT USE ISSUE |
5 |
| 23 |
PRURITUS |
5 |
| 24 |
PSORIASIS |
5 |
| 25 |
SKIN EXFOLIATION |
5 |
| 26 |
XEROSIS |
5 |
| 27 |
BASAL CELL CARCINOMA |
4 |
| 28 |
DRUG HYPERSENSITIVITY |
4 |
| 29 |
DRY EYE |
4 |
| 30 |
ECZEMA |
4 |
| 31 |
HYPERSENSITIVITY |
4 |
| 32 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
4 |
| 33 |
MALAISE |
4 |
| 34 |
PAIN OF SKIN |
4 |
| 35 |
SKIN BURNING SENSATION |
4 |
| 36 |
SOMNOLENCE |
4 |
| 37 |
THERAPEUTIC RESPONSE UNEXPECTED |
4 |
| 38 |
ANXIETY |
3 |
| 39 |
ASTHENIA |
3 |
| 40 |
BURNING SENSATION |
3 |
| 41 |
CHEILITIS |
3 |
| 42 |
COUGH |
3 |
| 43 |
HEART RATE INCREASED |
3 |
| 44 |
HOSPITALISATION |
3 |
| 45 |
ILLNESS |
3 |
| 46 |
INTENTIONAL PRODUCT MISUSE |
3 |
| 47 |
MOOD ALTERED |
3 |
| 48 |
NAUSEA |
3 |
| 49 |
PIGMENTATION DISORDER |
3 |
| 50 |
RASH ERYTHEMATOUS |
3 |
| 51 |
SENSITIVE SKIN |
3 |
| 52 |
SKIN DISCOLOURATION |
3 |
| 53 |
SKIN HYPERPIGMENTATION |
3 |
| 54 |
SKIN IRRITATION |
3 |
| 55 |
UNDERDOSE |
3 |
| 56 |
URTICARIA |
3 |
| 57 |
WEIGHT DECREASED |
3 |
| 58 |
ABDOMINAL DISCOMFORT |
2 |
| 59 |
ABDOMINAL PAIN UPPER |
2 |
| 60 |
ABNORMAL LOSS OF WEIGHT |
2 |
| 61 |
ACNE CYSTIC |
2 |
| 62 |
ADVERSE EVENT |
2 |
| 63 |
APPLICATION SITE DISCHARGE |
2 |
| 64 |
APPLICATION SITE DISCOLOURATION |
2 |
| 65 |
APPLICATION SITE EXFOLIATION |
2 |
| 66 |
BACK PAIN |
2 |
| 67 |
CHOLECYSTITIS ACUTE |
2 |
| 68 |
CHOLESTASIS |
2 |
| 69 |
CONTUSION |
2 |
| 70 |
DEATH |
2 |
| 71 |
DECREASED APPETITE |
2 |
| 72 |
DRUG INTOLERANCE |
2 |
| 73 |
DRY MOUTH |
2 |
| 74 |
DYSPHAGIA |
2 |
| 75 |
DYSPNOEA |
2 |
| 76 |
EYE IRRITATION |
2 |
| 77 |
EYE PAIN |
2 |
| 78 |
FALL |
2 |
| 79 |
GASTROINTESTINAL HAEMORRHAGE |
2 |
| 80 |
HYPERHIDROSIS |
2 |
| 81 |
IMMUNE SYSTEM DISORDER |
2 |
| 82 |
IMMUNE-MEDIATED HEPATITIS |
2 |
| 83 |
INFECTION |
2 |
| 84 |
INFLAMMATION |
2 |
| 85 |
INTENTIONAL PRODUCT USE ISSUE |
2 |
| 86 |
INTENTIONAL UNDERDOSE |
2 |
| 87 |
JOINT SWELLING |
2 |
| 88 |
LENTIGO |
2 |
| 89 |
LUNG NEOPLASM MALIGNANT |
2 |
| 90 |
MELANOCYTIC NAEVUS |
2 |
| 91 |
MILIARIA |
2 |
| 92 |
MIOSIS |
2 |
| 93 |
MUSCLE SPASMS |
2 |
| 94 |
MYALGIA |
2 |
| 95 |
OVERDOSE |
2 |
| 96 |
PAIN IN EXTREMITY |
2 |
| 97 |
PERIPHERAL SWELLING |
2 |
| 98 |
PNEUMONIA |
2 |
| 99 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
2 |
| 100 |
PRODUCT DOSE OMISSION ISSUE |
2 |
| 101 |
PRODUCT QUALITY ISSUE |
2 |
| 102 |
PSORIATIC ARTHROPATHY |
2 |
| 103 |
PYREXIA |
2 |
| 104 |
RASH MACULAR |
2 |
| 105 |
RASH PAPULAR |
2 |
| 106 |
RASH PRURITIC |
2 |
| 107 |
SEBORRHOEIC KERATOSIS |
2 |
| 108 |
SEIZURE |
2 |
| 109 |
SKIN HAEMORRHAGE |
2 |
| 110 |
SKIN LESION |
2 |
| 111 |
SKIN WARM |
2 |
| 112 |
SQUAMOUS CELL CARCINOMA |
2 |
| 113 |
SWELLING |
2 |
| 114 |
TACHYCARDIA |
2 |
| 115 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
2 |
| 116 |
THERAPEUTIC PRODUCT INEFFECTIVE |
2 |
| 117 |
ABDOMINAL DISTENSION |
1 |
| 118 |
ABDOMINAL PAIN |
1 |
| 119 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
| 120 |
ACTINIC KERATOSIS |
1 |
| 121 |
ACUTE KIDNEY INJURY |
1 |
| 122 |
ACUTE PULMONARY OEDEMA |
1 |
| 123 |
ADDISON^S DISEASE |
1 |
| 124 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
| 125 |
ALOPECIA |
1 |
| 126 |
AMMONIA INCREASED |
1 |
| 127 |
ANAEMIA |
1 |
| 128 |
ANAL FISTULA |
1 |
| 129 |
ANGIOPATHY |
1 |
| 130 |
APPLICATION SITE HAEMORRHAGE |
1 |
| 131 |
APPLICATION SITE IRRITATION |
1 |
| 132 |
APPLICATION SITE NODULE |
1 |
| 133 |
APPLICATION SITE PRURITUS |
1 |
| 134 |
APPLICATION SITE RASH |
1 |
| 135 |
APPLICATION SITE SCAB |
1 |
| 136 |
APPLICATION SITE SWELLING |
1 |
| 137 |
APPLICATION SITE VESICLES |
1 |
| 138 |
ARTHROPOD STING |
1 |
| 139 |
ASCITES |
1 |
| 140 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
| 141 |
ASPIRATION |
1 |
| 142 |
ASTHMA |
1 |
| 143 |
ATRIAL FIBRILLATION |
1 |
| 144 |
B-CELL SMALL LYMPHOCYTIC LYMPHOMA |
1 |
| 145 |
BACK DISORDER |
1 |
| 146 |
BACTERIAL INFECTION |
1 |
| 147 |
BALANCE DISORDER |
1 |
| 148 |
BLOOD CALCIUM INCREASED |
1 |
| 149 |
BLOOD CHOLESTEROL INCREASED |
1 |
| 150 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
1 |
| 151 |
BLOOD GLUCOSE INCREASED |
1 |
| 152 |
BLOOD PRESSURE DECREASED |
1 |
| 153 |
BLOOD PRESSURE INCREASED |
1 |
| 154 |
BRONCHOSPASM |
1 |
| 155 |
C-REACTIVE PROTEIN |
1 |
| 156 |
CARDIAC MURMUR |
1 |
| 157 |
CARDIOMEGALY |
1 |
| 158 |
CATARACT OPERATION |
1 |
| 159 |
CEREBROVASCULAR ACCIDENT |
1 |
| 160 |
CHEMICAL BURN |
1 |
| 161 |
CHEMICAL BURNS OF EYE |
1 |
| 162 |
CHEST PAIN |
1 |
| 163 |
CONFUSIONAL STATE |
1 |
| 164 |
CONJUNCTIVITIS ALLERGIC |
1 |
| 165 |
CONSTIPATION |
1 |
| 166 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
| 167 |
CONVULSION |
1 |
| 168 |
COVID-19 |
1 |
| 169 |
DEHYDRATION |
1 |
| 170 |
DERMATITIS CONTACT |
1 |
| 171 |
DERMATITIS PSORIASIFORM |
1 |
| 172 |
DIABETES MELLITUS |
1 |
| 173 |
DISABILITY |
1 |
| 174 |
DISCOMFORT |
1 |
| 175 |
DISEASE PROGRESSION |
1 |
| 176 |
DISEASE RECURRENCE |
1 |
| 177 |
DROOLING |
1 |
| 178 |
DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
1 |
| 179 |
DRUG EFFECT INCOMPLETE |
1 |
| 180 |
DRUG EFFECT LESS THAN EXPECTED |
1 |
| 181 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
1 |
| 182 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
| 183 |
DYSPEPSIA |
1 |
| 184 |
DYSPNOEA EXERTIONAL |
1 |
| 185 |
ENCEPHALITIS |
1 |
| 186 |
ENDOMETRIOSIS |
1 |
| 187 |
EPISTAXIS |
1 |
| 188 |
EXPIRED PRODUCT ADMINISTERED |
1 |
| 189 |
EXPOSURE TO MOULD |
1 |
| 190 |
EYE OEDEMA |
1 |
| 191 |
FACIAL ASYMMETRY |
1 |
| 192 |
FEELING HOT |
1 |
| 193 |
FLATULENCE |
1 |
| 194 |
FLUSHING |
1 |
| 195 |
FREQUENT BOWEL MOVEMENTS |
1 |
| 196 |
FUNGAL OESOPHAGITIS |
1 |
| 197 |
GAIT DISTURBANCE |
1 |
| 198 |
GASTRIC ULCER |
1 |
| 199 |
GASTROENTERITIS VIRAL |
1 |
| 200 |
GASTROINTESTINAL DISORDER |
1 |
| 201 |
GASTROINTESTINAL MELANOSIS |
1 |
| 202 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
| 203 |
GLOSSODYNIA |
1 |
| 204 |
GUTTATE PSORIASIS |
1 |
| 205 |
HAEMANGIOMA |
1 |
| 206 |
HAEMATURIA |
1 |
| 207 |
HAEMORRHAGE |
1 |
| 208 |
HAIR COLOUR CHANGES |
1 |
| 209 |
HEAVY EXPOSURE TO ULTRAVIOLET LIGHT |
1 |
| 210 |
HEPATITIS |
1 |
| 211 |
HOT FLUSH |
1 |
| 212 |
HYPERAESTHESIA |
1 |
| 213 |
HYPEREOSINOPHILIC SYNDROME |
1 |
| 214 |
HYPERGLYCAEMIA |
1 |
| 215 |
HYPERKERATOSIS |
1 |
| 216 |
HYPERSOMNIA |
1 |
| 217 |
HYPERTENSION |
1 |
| 218 |
HYPERTRIGLYCERIDAEMIA |
1 |
| 219 |
HYPOPHAGIA |
1 |
| 220 |
HYPOTENSION |
1 |
| 221 |
IMMUNOSUPPRESSION |
1 |
| 222 |
INCORRECT DOSAGE ADMINISTERED |
1 |
| 223 |
INCORRECT DRUG ADMINISTRATION DURATION |
1 |
| 224 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
1 |
| 225 |
INCORRECT PRODUCT STORAGE |
1 |
| 226 |
INFLUENZA LIKE ILLNESS |
1 |
| 227 |
INJECTION SITE DRYNESS |
1 |
| 228 |
INJECTION SITE HAEMORRHAGE |
1 |
| 229 |
INJECTION SITE MASS |
1 |
| 230 |
INJECTION SITE PAIN |
1 |
| 231 |
INJECTION SITE PRURITUS |
1 |
| 232 |
INJECTION SITE REACTION |
1 |
| 233 |
INJECTION SITE SWELLING |
1 |
| 234 |
INJURY ASSOCIATED WITH DEVICE |
1 |
| 235 |
INSOMNIA |
1 |
| 236 |
INTENTIONAL DOSE OMISSION |
1 |
| 237 |
JAUNDICE |
1 |
| 238 |
JOINT WARMTH |
1 |
| 239 |
LIP DRY |
1 |
| 240 |
LIVER FUNCTION TEST INCREASED |
1 |
| 241 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
| 242 |
LOW DENSITY LIPOPROTEIN INCREASED |
1 |
| 243 |
MALIGNANT MELANOMA IN SITU |
1 |
| 244 |
MENINGITIS VIRAL |
1 |
| 245 |
METASTATIC MALIGNANT MELANOMA |
1 |
| 246 |
MIGRAINE |
1 |
| 247 |
MOBILITY DECREASED |
1 |
| 248 |
MOUTH ULCERATION |
1 |
| 249 |
MUSCLE DISORDER |
1 |
| 250 |
MUSCULAR WEAKNESS |
1 |
| 251 |
MUSCULOSKELETAL DISCOMFORT |
1 |
| 252 |
MUSCULOSKELETAL STIFFNESS |
1 |
| 253 |
MYELOSUPPRESSION |
1 |
| 254 |
NAIL DISORDER |
1 |
| 255 |
NASAL CONGESTION |
1 |
| 256 |
NASAL OEDEMA |
1 |
| 257 |
NASOPHARYNGITIS |
1 |
| 258 |
NEPHROLITHIASIS |
1 |
| 259 |
NERVE INJURY |
1 |
| 260 |
NEUTROPENIA |
1 |
| 261 |
NODULE |
1 |
| 262 |
OCULAR HYPERAEMIA |
1 |
| 263 |
OCULAR ICTERUS |
1 |
| 264 |
OEDEMA |
1 |
| 265 |
OESOPHAGEAL ULCER |
1 |
| 266 |
ORGANISING PNEUMONIA |
1 |
| 267 |
OSTEOMYELITIS |
1 |
| 268 |
OXYGEN SATURATION DECREASED |
1 |
| 269 |
PALPITATIONS |
1 |
| 270 |
PETECHIAE |
1 |
| 271 |
PINGUECULA |
1 |
| 272 |
PLASMA CELL MYELOMA |
1 |
| 273 |
POOR QUALITY PRODUCT ADMINISTERED |
1 |
| 274 |
PRE-EXISTING CONDITION IMPROVED |
1 |
| 275 |
PRODUCT ADMINISTRATION INTERRUPTED |
1 |
| 276 |
PRODUCT DOSE OMISSION |
1 |
| 277 |
PRODUCT STORAGE ERROR |
1 |
| 278 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
| 279 |
PRODUCTIVE COUGH |
1 |
| 280 |
PSYCHOTIC DISORDER |
1 |
| 281 |
PULMONARY EMBOLISM |
1 |
| 282 |
PULMONARY HAEMORRHAGE |
1 |
| 283 |
PYOGENIC GRANULOMA |
1 |
| 284 |
RALES |
1 |
| 285 |
RASH MACULO-PAPULAR |
1 |
| 286 |
RECTAL HAEMORRHAGE |
1 |
| 287 |
RED BLOOD CELL COUNT INCREASED |
1 |
| 288 |
RESPIRATORY DISORDER |
1 |
| 289 |
RESPIRATORY FAILURE |
1 |
| 290 |
RETINAL HAEMORRHAGE |
1 |
| 291 |
SCAB |
1 |
| 292 |
SCAR |
1 |
| 293 |
SCLERODERMA |
1 |
| 294 |
SCRATCH |
1 |
| 295 |
SEBORRHOEIC DERMATITIS |
1 |
| 296 |
SELF-INJURIOUS IDEATION |
1 |
| 297 |
SEPSIS |
1 |
| 298 |
SKIN ATROPHY |
1 |
| 299 |
SKIN CANCER |
1 |
| 300 |
SKIN DEPIGMENTATION |
1 |
| 301 |
SKIN DISCOMFORT |
1 |
| 302 |
SKIN DISORDER |
1 |
| 303 |
SKIN MASS |
1 |
| 304 |
SKIN PLAQUE |
1 |
| 305 |
SKIN REACTION |
1 |
| 306 |
SKIN TIGHTNESS |
1 |
| 307 |
SLEEP DISORDER |
1 |
| 308 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
1 |
| 309 |
SOLAR DERMATITIS |
1 |
| 310 |
SPINAL DISORDER |
1 |
| 311 |
STOMATITIS |
1 |
| 312 |
SUICIDAL IDEATION |
1 |
| 313 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
1 |
| 314 |
TACHYPNOEA |
1 |
| 315 |
THIRST |
1 |
| 316 |
TONGUE ULCERATION |
1 |
| 317 |
TRIGGER FINGER |
1 |
| 318 |
TYPE 2 DIABETES MELLITUS |
1 |
| 319 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
| 320 |
URINARY INCONTINENCE |
1 |
| 321 |
URINARY RETENTION |
1 |
| 322 |
VASCULAR INJURY |
1 |
| 323 |
VASCULITIS |
1 |
| 324 |
VISION BLURRED |
1 |
| 325 |
VITILIGO |
1 |
| 326 |
VITREOUS HAEMORRHAGE |
1 |
| 327 |
VOMITING |
1 |
| 328 |
VON WILLEBRAND^S DISEASE |
1 |
| 329 |
WALKING DISABILITY |
1 |
| 330 |
WEIGHT INCREASED |
1 |
| 331 |
WOUND |
1 |